PARIS, FRANCE, FRANCE, June 3, 2025 /EINPresswire.com/ -- On the occasion of World Multiple Sclerosis Day, Ad Scientiam announced that MSCopilot ®, its class IIa ...
PARIS, FRANCE, February 26, 2025 /EINPresswire.com/ -- Ad Scientiam, a pioneering MedTech company specialized in digital biomarkers, announced today the launch of MS ...
Multiple Sclerosis (MS) is a chronic immune-mediated disease of the central nervous system that affects 2.8 million people worldwide. The disease is characterized by early inflammatory demyelination ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results